FEI establishment
Glaxo Smith Kline
FDA establishment FEI 3004006471 · Parsippany, United States
Key facts
| FEI number | 3004006471 |
|---|---|
| Legal name | Glaxo Smith Kline |
| City | Parsippany |
| Country | United States |
| Product types | Drugs |
| Last inspection | Feb 25, 2004 |
At a glance
- 1–9 FDA inspections
- None No Action Indicated (NAI)
- 1–9 Voluntary Action Indicated (VAI)
- None Official Action Indicated (OAI)
- 1–9 Inspections with a Form 483
- 1–9 Citations
- None Repeat citations
- None Warning letters
- None Linked 510(k)s
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA establishments (FEI)
An FEI (FDA Establishment Identifier) is the number the FDA assigns to a site it inspects. FEIs of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection and compliance data